Hi there. Price is forming a continuation pattern to the upside. Watch strong price action at the current levels for buy.
European Commission’s independent experts selected Humanigen’s Lenzilumab as One of the 10 Most Promising Treatments for COVID-19! CEO of Humanigen said today: "We look forward to continuing our discussions with colleagues at the European Medicines Agency to advance our efforts to submit a marketing authorization application for lenzilumab in COVID-19". In the...
Investors should continue to watch Merck and how it plays out here at the 80 level as their COVID drug treatment is pending approval. I believe the market is absolutely sleeping on the significance of this drug and the kind of impact it will have. A treatment is an absolute game changer provided the politics of COVID do not disrupt innovation, transparency and...
Idea for MRNA: - Good level for reversal. Aug 13 is the capitulation date. - Stop is at 41 degrees. - Gamma squeeze bubble ends with big deflation. TP1: Gap fill 260~ PT 0.5 retrace of move: GLHF - DPT
Moderna broke weekly support making this very vulnerable towards 237-250$/share. Will fall pretty hard in coming days - weeks iMO. Overvalued af in the high 400's nearly cut in half but not quite yet .. currently in puts.
Hello my beauties. I think MRNA has entered a distribution range, as the ST (second test) seemed to be pretty weak, and the price is now showing weakness below the trading range. We are going to wait for further developments in price action and eventually take a trade on the final LPSY. For those of you who like trading ranges, this might be a juicy opportunity....
MYX:PHARMA With recent business deal signings will the punters back to this counter? From 2-3 days observation, personally this counter may still overlooked with addition of MCO 2.0 being introduced - the volume is just not there (yet?) Like it or not 14mils doses has been bought even some may decries the subpar 50%++ effective rate of Sinovac covid19...
Still swinging Pfizer calls. Bullish divergence on RSI indicator 1HR Still holding longer term uptrend. Mid October - NOV 45Cs as an idea or credit spread 45/40P Break below black line invalidates trade idea
Pfizer appears to have completed retracement from high's , found support on 100EMA cloud and indicating a change in momentum for a possible nice swing trade. Optimal buy zone would be black trend line but I'm going with starter $45 10/15Cs here. Will add if it continues to dip up until 43 stop loss.
First off, this is not meant as any opinion towards Covid-19 (political, medical, or otherwise) nor meant in any way to dishonor any who have lost loved ones due to Covid-19, but rather I wanted to call out an interesting correlation that looks to be occurring. Recently TradingView made the confirmed cases in the US available broken down per state or country....
Large cap Stonks collapse in a *rising rates environment. Not too mention covid is all but a 2020 nightmare at this point. Wall Street is sooo complacent.. "Only Buy Fam" they all repeat... Go Small caps! #MSOgang
Stonk. #MSOgang small caps. Investing ain't easy. Rule # whatever, don't be cute. Vaccine play is overplayed. 2021 is not a repeat of '20. A rising rate environment is in works. $GNLN #thegem #cannabisreform
Due to significant fundamental shift, the company seems to be cheap, judging by past data.
SESN received a preapproval for the dug, Vicineum, but not in its present form. and the market overreacted to it. sold at market prices. and the price went down to 0.86usd, its strongest support. The FDA has determined that it cannot approve the BLA for Vicineum in its present form and has provided recommendations specific to additional clinical/statistical data...
On 7/15/2021 Jefferies Financial Group brokerage Boosted the Price Target from Positive to Hold from $170.00 to $250.00 On 5/7/2021 Morgan Stanley brokerage Lowered the Price Target to Equal Weight from $201.00 to $190.00 On 5/7/2021 The Goldman Sachs Group brokerage Boosted the Price Target to Buy from $206.00 to $228.00 My price target for MRNA is the Fib...
Hi TV Community! I just got settled into my new place and wanted to do a quick ta on pfizer. This stock has been experiencing large call option buying recently and the price action supports this bullish context. We are breaking above important areas with ease and my target resistance level would be the upper yellow trendline. As we continue to see devastating...
On 6/11/2021 Piper Sandler brokerage Initiated Coverage giving a price target of $18.00 VXRT Vaxart today announced that it has shown for the first time in clinical trials that its oral tablet vaccine platform successfully boosted immune responses in subjects previously vaccinated with a Vaxart oral vaccine more than a year earlier. (prnewswire.com) This is in...
Dyadic International signed a COVID-19 vaccine technology transfer and licensing agreement with the Rubic Consortium. The Rubic Consortium is made up of promoters of the project representing public health, medical, academia, vaccine technology, technology transfer and economics sectors. Arrangement includes C1 COVID-19 vaccine technology transfer and licensing...